1. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment. Issue 12 (December 2018) Authors: Shen, Jing; Najafi, Sara; Stäble, Sina; Fabian, Johannes; Koeneke, Emily; Kolbinger, Fiona; Wrobel, Jagoda; Meder, Benjamin; Distel, Martin; Heimburg, Tino; Sippl, Wolfgang; Jung, Manfred; Peterziel, Heike; Kranz, Dominique; Boutros, Michael; Westermann, Frank; Witt, Olaf; Oehme, Ina Journal: Cell death and differentiation Issue: Volume 25:Issue 12(2018) Page Start: 2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, double‐blind, placebo‐controlled, clinical trial to evaluate the benefits of Nigella sativa seeds oil in reducing cardiovascular risks in hypertensive patients. (6th May 2021) Authors: Shoaei‐Hagh, Parisa; Kamelan Kafi, Farzaneh; Najafi, Sara; Zamanzadeh, Mansoureh; Heidari Bakavoli, Alireza; Ramezani, Javad; Soltanian, Samira; Asili, Javad; Hosseinzadeh, Hossein; Eslami, Saeid; Taherzadeh, Zhila Journal: Phytotherapy research Issue: Volume 35:Number 8(2021) Page Start: 4388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiovascular protection conferred by glucagon‐like peptide‐1 receptor agonists: A role for serum uric acid reduction?. Issue 9 (16th May 2022) Authors: Najafi, Sara; Bahrami, Milad; Butler, Alexandra E.; Sahebkar, Amirhossein Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 9(2022) Page Start: 4237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ERBB and P‐glycoprotein inhibitors break resistance in relapsed neuroblastoma models through P‐glycoprotein. Issue 1 (5th November 2022) Authors: Rösch, Lisa; Herter, Sonja; Najafi, Sara; Ridinger, Johannes; Peterziel, Heike; Cinatl, Jindrich; Jones, David T. W.; Michaelis, Martin; Witt, Olaf; Oehme, Ina Journal: Molecular oncology Issue: Volume 17:Issue 1(2023) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hypoxia-Induced miR-210 Overexpression Promotes the Differentiation of Human-Induced Pluripotent Stem Cells to Hepatocyte-Like Cells on Random Nanofiber Poly-L-Lactic Acid/Poly (ε-Caprolactone) Scaffolds. (22nd November 2021) Authors: Mobarra, Naser; Raji, Sara; Najafi, Sara; Kafi, Farzaneh Kamelan; Ferns, Gordon A.; Pakzad, Reza Other Names: Muriel Pablo Academic Editor. Journal: Oxidative medicine and cellular longevity Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incidence of infectious diseases after earthquakes: a systematic review and meta-analysis. (January 2022) Authors: Najafi, Sara; Akahavan Rezayat, Arash; Beyzaei, Seyyedeh Faezeh; Shahriari, Zahra; Taheri tabar, Mahdieh; Ghasemi Nour, Mohammad; Mosaed, Reza; Khadem-Rezaiyan, Majid; Hamidi Farahani, Ramin Journal: Public health Issue: Volume 202(2022) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LGG-25. The first-in-class ERK inhibitor ulixertinib (BVD-523) shows activity in MAPK-driven pediatric low-grade glioma models as single agent and in combination with MEK inhibitors or senolytics. (3rd June 2022) Authors: Sigaud, Romain; Rösch, Lisa; Gatzweiler, Charlotte; Benzel, Julia; von Soosten, Laura; Peterziel, Heike; Najafi, Sara; Ayhan, Simay; Gerloff, Xena F; Hofmann, Nina; Büdenbender, Isabel; Foerster, Kathrin I; Burhenne, Jürgen; Longuespée, Rémi; van Tilburg, Cornelis M; Jones, David T W; Pfister, St... Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 1 Page Start: i93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mortality risk factors in kidney‐transplanted patients with COVID‐19: A systematic review and regression analysis. Issue 4 (4th November 2021) Authors: Navari, Yasaman; Bagheri, Amir Behzad; Akhavan Rezayat, Arash; SeyedAlinaghi, SeyedAhmad; Najafi, Sara; Barzegary, Alireza; Asadollahi‐Amin, Ali Journal: Health science reports Issue: Volume 4:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis. Issue 8 (17th April 2022) Authors: Najafi, Sara; Bahrami, Milad; Butler, Alexandra E.; Sahebkar, Amirhossein Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 8(2022) Page Start: 3627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The effect of glucagon‐like peptide‐1 receptor agonists on serum uric acid concentration: A systematic review and meta‐analysis. Issue 8 (17th April 2022) Authors: Najafi, Sara; Bahrami, Milad; Butler, Alexandra E.; Sahebkar, Amirhossein Journal: British journal of clinical pharmacology Issue: Volume 88:Issue 8(2022) Page Start: 3627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗